- Home
- STRO vs DBI Comparison
STRO vs DBI Comparison
Compare STRO & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- DBI
- Stock Information
- Founded
- STRO 2003
- DBI 1991
- Country
- STRO United States
- DBI United States
- Employees
- STRO N/A
- DBI N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- DBI Clothing/Shoe/Accessory Stores
- Sector
- STRO Health Care
- DBI Consumer Discretionary
- Exchange
- STRO Nasdaq
- DBI Nasdaq
- Market Cap
- STRO 172.8M
- DBI 292.2M
- IPO Year
- STRO 2018
- DBI 1991
- Fundamental
- Price
- STRO $1.94
- DBI $5.55
- Analyst Decision
- STRO Strong Buy
- DBI Hold
- Analyst Count
- STRO 7
- DBI 2
- Target Price
- STRO $12.14
- DBI $5.75
- AVG Volume (30 Days)
- STRO 1.4M
- DBI 2.1M
- Earning Date
- STRO 11-13-2024
- DBI 12-10-2024
- Dividend Yield
- STRO N/A
- DBI 3.68%
- EPS Growth
- STRO N/A
- DBI N/A
- EPS
- STRO N/A
- DBI N/A
- Revenue
- STRO $160,955,000.00
- DBI $3,050,038,000.00
- Revenue This Year
- STRO N/A
- DBI N/A
- Revenue Next Year
- STRO N/A
- DBI $2.23
- P/E Ratio
- STRO N/A
- DBI N/A
- Revenue Growth
- STRO 230.90
- DBI N/A
- 52 Week Low
- STRO $1.70
- DBI $4.36
- 52 Week High
- STRO $6.13
- DBI $11.57
- Technical
- Relative Strength Index (RSI)
- STRO 28.52
- DBI 46.98
- Support Level
- STRO $1.70
- DBI $5.18
- Resistance Level
- STRO $1.93
- DBI $6.21
- Average True Range (ATR)
- STRO 0.20
- DBI 0.43
- MACD
- STRO -0.01
- DBI -0.05
- Stochastic Oscillator
- STRO 12.60
- DBI 42.47
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.